[
    "{\"step_by_step_thinking\": \"The patient has a T-score of -2.6 SD, which indicates osteoporosis. The drug that is used to treat osteoporosis and also reduces the risk of breast cancer is a selective estrogen receptor modulator (SERM), such as raloxifene. SERMs have estrogen-like effects on bone and anti-estrogen effects on the breast and endometrium. However, they also increase the risk of venous thromboembolism, including deep vein thrombosis.\", \"answer_choice\": \"D. Deep vein thrombosis\"}"
]